Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colonic Neoplasms 2Neurologic Manifestations 1Neuroendocrine Tumors 1Neoplasms 1Lymphoma 1Leukemia 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Attention Deficit Disorder with Hyperactivity 1

Interventions

Gene Expression Profiling 9Blood Specimen Collection 6Polymerase Chain Reaction 5Immunohistochemistry 5Amplified Fragment Length Polymorphism Analysis 5Surveys and Questionnaires 3Sunitinib 3Reverse Transcriptase Polymerase Chain Reaction 3Flow Cytometry 3Biopsy 3Surgical Procedures, Operative 2Radiotherapy 2Radiosurgery 2Patient Reported Outcome Measures 2Observation 2Nivolumab 2Microarray Analysis 2Immunotherapy 2Genetic Testing 2Drug Therapy 2DNA Methylation 2Cytogenetic Analysis 2tremelimumab 1pembrolizumab 1durvalumab 1atezolizumab 1aldesleukin 1X-Rays 1Watchful Waiting 1Tomography, Optical Coherence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Kidney Neoplasms × Cytidine Triphosphate × Clear all
NCT02086734 2018-10-02

Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma

Ludwig-Maximilians - University of Munich

Completed
60 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡